The serpins (Serine Protease Inhibitors) are a superfamily of proteins which are involved in many important physiological processes such as blood coagulation and inflammation. The superfamily includes well-characterised inhibitors such as ulantitrypin and antithrombin 111 [1, 2] as well as the noninhibitory proteins ovalbumin and angiotensinogen. A sub-family of ovalbumin-like serpins [3] includes four human proteins: PAI-2, leukocyte elastase inhibitor, placental thrombin inhibitor, and the squamous cell carcinoma antigen (SCCA). SCCA is a tumour-associated antigen first detected in squamous cell carcinoma tissue of the uterine cervix [4] . The serum levels of SCCA are believed to reflect the degree of metastasis of cervical carcinomas, and a role for SCCA in tumour development has been proposed [51.
We have recently found a further ov-serpin gene, leupin which has 92% sequence identity to SCCA (Barnes & Worrall, unpublished data). The two genes differ greatly in their reactive loop sequences, with leupin having a leucine residue at its predicted PI position where SCCA has a serine, suggesting that they may inhibit different target proteases. Leupin was initially identified by screening genomic DNA using PCR to amplify sequences between 2 conserved regions of known serpins. Since then, the full length gene has been cloned from HeLa cells, and both strands have been sequenced. An alignment of the SCCA and leupin reactive site loop sequences is shown below. Expression of SCCA and leupin was initially studied using Southern blotting techniques with specific probes. However, due to the high degree of similarity between the two sequences, crossreactivity of the probes occurred suggesting that previous expression studies of SCCA using antibodies and nucleotide hybridisation will have also detected leupin. To overcome this, we have designed oligonucleotides which are specific to the corresponding reactive loops of leupin and SCCA (Fig.1) . RNA was isolated from a range of human cell lines and tissues and RT-PCR was performed using the specific oligonucleotide primers to detect and compare expression of SCCA and leupin. Fiaure 2 : Expression of (a) leupin and (b) SCCA in human tissues. Total RNA was isolated and RT-PCR was performed using random hexonucleotides, and specific primers to each gene. Products were separated on 1% agarose and detected by ethidium bromide staining. Lane (Fig 2) . The predicted molecular weight of leupin is 44,857 and its predicted isoelectric point is 6.04 which is consistent with the acidic form of SCCA. The presence of leupin in the same cell types as SCCA may explain the heterogeneity seen previously with SCCA. Furthermore, SCCA has recently been shown to inhibit Cathepsin L [7] . This inhibitory ability may be a property of either SCCA or leupin since protein preparations would contain both of these serpins.
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